Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Radiofrequency ablation for benign thyroid nodules in LatinX patients

Official title: Study of the Use of Radiofrequency Ablation in LatinX Patients With Symptomatic Benign Thyroid Nodules

Run by Northwell Health · NCT05903196 · Data updated 2026-11-12

This study is testing if a new, less invasive treatment called radiofrequency ablation can safely help LatinX patients with bothersome benign thyroid nodules feel better.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment44 (estimated)
SponsorNorthwell Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedDecember 1, 2029
Study endsDecember 30, 2029
Registry record updatedNovember 2, 2026
Trial IDNCT05903196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are LatinX individuals over 18 years old with benign, symptomatic thyroid nodules that meet specific ultrasound criteria.

Probably not a fit

Patients with malignant nodules, those who are pregnant or breastfeeding, or individuals with certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of radiofrequency ablation (RFA) as a minimally invasive treatment for benign symptomatic thyroid nodules in LatinX patients. Traditionally, surgery was the primary treatment option, but RFA offers a safer alternative that can be performed in a clinic setting without the risks associated with surgery. Participants will undergo the RFA procedure and will be monitored for effectiveness and side effects over 18 months. The study aims to determine if RFA is a safe and effective option for this specific population, which has not been extensively studied before.

Why it matters

Potential benefit: If successful, this treatment could provide a safer, non-surgical option for LatinX patients suffering from symptomatic benign thyroid nodules.

How similar studies have gone: While evidence supporting RFA for thyroid nodules exists internationally, this specific study focusing on LatinX patients is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject capable of giving informed consent
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Subjects over 18 years of age
* Subject who self-identifies as LatinX
* Subjects who have a benign, symptomatic thyroid nodule
* Subjects whose nodule has well-defined margin on ultrasound and is surrounded by at least 2mm of normal thyroid parenchyma in all directions

Exclusion Criteria:

* Patients who are pregnant, trying to become pregnant, or breastfeeding
* Patient who have a cardiac pacemaker,defibrillator , or other electromedical equipment
* Patients who have a nodule that is malignant or not predominantly solid (must be \>50% solid by ultrasound)
* Patients who cannot give consent
* Patients on anticoagulation or dual antiplatelet therapy
* Patients with acute illness
* People with BP \> 140/90 prior to the scheduled procedure

Where it's running

  • Northwell Health Physician Partners
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.